Skip to main content

Table 5 Comparison of clinical and biological variables at ICU admission between survivor and non-survivor septic patients

From: Diagnostic and prognostic value of soluble CD14 subtype (Presepsin) for sepsis and community-acquired pneumonia in ICU patients

  Survivors
75
Non-survivors
25
p value
Sex (male/female) 43/32 18/7 0.06
Age, years (mean ± SD) 56.2 ± 19 64.6 ± 12 0.04
SAPS II, median (IQR) 41 (30–54) 65 (53–78) <0.0001
SOFA, median (IQR) 7 (5–10) 10.5 (8–13) <0.0001
Creatininemia, median (IQR), (μmol/L) 80 (32–103) 39 (20–68) 0.01
PCT, median (IQR), (ng/mL) 0.89 (0.20–11.4) 4.67 (1.89–24.8) 0.005
hsCRP, median (IQR), (mg/L) 95 (38–233) 150 (48–245) 0.24
Presepsin, median (IQR), (pg/mL) 871 (449–1828) 1734 (1014–3128) 0.0002
ICU length of stay, median (IQR), (days) 4 (2–11) 4 (2–10) 0.53
  1. SAPS simplified acute physiology score, SOFA sequential organ failure assessment score, PCT procalcitonin, hsCRP high-sensitivity C-reactive protein
  2. p: differences between survivor and non-survivor septic patients